CoChat

Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis

Open access
Koul, Anil, Vranckx, Luc, Dendouga, Najoua, Balemans, Wendy, Van den Wyngaert, Ilse, Vergauwen, Karen, Göhlmann, Hinrich W.H., Willebrords, Rudy, Poncelet, Alain, Guillemont, Jerome, Bald, Dirk, Andries, Koen · 2008 · Journal of Biological Chemistry

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

An estimated one-third of the world population is latently infected with Mycobacterium tuberculosis. These nonreplicating, dormant bacilli are tolerant to conventional anti-tuberculosis drugs, such as isoniazid. We recently identified diarylquinoline R207910 (also called TMC207) as an inhibitor of ATP synthase with a remarkable activity against replicating mycobacteria. In the present study, we show that R207910 kills dormant bacilli as effectively as aerobically grown bacilli with the same target specificity. Despite a transcriptional down-regulation of the ATP synthase operon and significantly lower cellular ATP levels, we show that dormant mycobacteria do possess residual ATP synthase enzymatic activity. This activity is blocked by nanomolar concentrations of R207910, thereby further reducing ATP levels and causing a pronounced bactericidal effect. We conclude that this residual ATP synthase activity is indispensable for the survival of dormant mycobacteria, making it a promising drug target to tackle dormant infections. The unique dual bactericidal activity of diarylquinolines on dormant as well as replicating bacterial subpopulations distinguishes them entirely from the current anti-tuberculosis drugs and underlines the potential of R207910 to shorten tuberculosis treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m803899200

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Effect of R207910 on wild type and resistant BK12 M. tuberculosis grown under oxygen depletion or NO stress. A , M. tuberculosis were grown under gradual O 2 depletion (Wayne model) for 18 days to induce dormancy, followed by treatment with different compounds for 4 days. B , killing of M. tuberculosis by R207910 under hypoxia growth conditions. The killing was measured after 7 days. C , killing by R207910 of NO-induced dormant M. tuberculosis . Dormancy was induced by a 2-h treatment with 150 𝛍 MofDETA/ NO. The killing was measured after 10 h.
FIGURE 1 Effect of R207910 on wild type and resistant BK12 M. tuberculosis grown under oxygen depletion or NO stress. A , M. tuberculosis were grown under gradual O 2 depletion (Wayne model) for 18 days to induce dormancy, followed by treatment with different compounds for 4 days. B , killing of M. tuberculosis by R207910 under hypoxia growth conditions. The killing was measured after 7 days. C , killing by R207910 of NO-induced dormant M. tuberculosis . Dormancy was induced by a 2-h treatment with 150 𝛍 MofDETA/ NO. The killing was measured after 10 h.CC-BY · From the PDF
FIGURE 2 Comparative R207910 killing kinetics for aerobically grown anddormant M.tuberculosis . R207910wastestedagainstdormant(Wayne) and aerobically grown cultures of M. tuberculosis. The dormant and aerobic cultures, with equal start A 600 values or comparable starting CFUs (10 7 to 10 8 CFU/ml), were treated with 10 𝛍 g/ml R207910 or 10 𝛍 g/ml isoniazid. Killing wasmonitored by measuring CFU/ml after 1, 4, 7, and 14 days on 7H10 plates and plotted as log 10 CFU reduction, calculated against nontreated controls. Note that for dormant mycobacteria treated with R207910 (10 𝛍 g/ml), the CFU counts were below the detection limit at 14 days (10 2 CFU/ml).
FIGURE 2 Comparative R207910 killing kinetics for aerobically grown anddormant M.tuberculosis . R207910wastestedagainstdormant(Wayne) and aerobically grown cultures of M. tuberculosis. The dormant and aerobic cultures, with equal start A 600 values or comparable starting CFUs (10 7 to 10 8 CFU/ml), were treated with 10 𝛍 g/ml R207910 or 10 𝛍 g/ml isoniazid. Killing wasmonitored by measuring CFU/ml after 1, 4, 7, and 14 days on 7H10 plates and plotted as log 10 CFU reduction, calculated against nontreated controls. Note that for dormant mycobacteria treated with R207910 (10 𝛍 g/ml), the CFU counts were below the detection limit at 14 days (10 2 CFU/ml).CC-BY · From the PDF
Image 3
CC-BY · From the PDF
FIGURE 4 ATP synthase is functional in dormant M. smegmatis . A , ATP synthesis activity in inverted membrane vesicles (50 𝛍 g/ml) from dormant M. smegmatis cultured for 10 days under Wayne O 2 depletion conditions. Positive control was membrane vesicles with buffer containing ADP, P i , and NADH, whereas negative control excluded NADH and Pi from the assay buffer. B , effect of R207910 on membrane potential in dormant M. smegmatis cultured for 10 days under Wayne O 2 depletion conditions. The membrane potential was measured using tetra-[ 3 H]phenylphosphonium bromide.
FIGURE 4 ATP synthase is functional in dormant M. smegmatis . A , ATP synthesis activity in inverted membrane vesicles (50 𝛍 g/ml) from dormant M. smegmatis cultured for 10 days under Wayne O 2 depletion conditions. Positive control was membrane vesicles with buffer containing ADP, P i , and NADH, whereas negative control excluded NADH and Pi from the assay buffer. B , effect of R207910 on membrane potential in dormant M. smegmatis cultured for 10 days under Wayne O 2 depletion conditions. The membrane potential was measured using tetra-[ 3 H]phenylphosphonium bromide.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 409

Metadata

Authors
Koul, A., Vranckx, L., Dendouga, N., Balemans, W., Van den Wyngaert, I., Vergauwen, K., Göhlmann, H. W. H., Willebrords, R., Poncelet, A., Guillemont, J., Bald, D., & Andries, K.
Affiliations
  • Johnson & Johnson (France) (FR)
  • Vrije Universiteit Amsterdam (NL)
Corresponding author
Koul, Anil
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2008-09
Volume
283
Issue
37
Pages
25273-25280
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2164282552
Cited by
364
References
31
Citations by year
2026: 16 · 2025: 17 · 2024: 10 · 2023: 19 · 2022: 16 · 2021: 22 · 2020: 23 · 2019: 25 · 2018: 17 · 2017: 25 · 2016: 15 · 2015: 20 · 2014: 29 · 2013: 20 · 2012: 22
FWCI
14.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Keywords
diarylquinolines, bedaquiline, Mycobacterium tuberculosis, dormant mycobacteria, latent tuberculosis infection, ATP synthase inhibition, ATP homeostasis, bactericidal activity, tuberculosis drug targets
MeSH terms
Adenosine Triphosphate, Antitubercular Agents, Homeostasis, Models, Biological, Mycobacterium, Mycobacterium bovis, Mycobacterium tuberculosis, Nitric Oxide, Oxygen, Quinolines, RNA, Messenger, Time Factors, Gene Expression Regulation, Bacterial, Mycobacterium smegmatis, Mitochondrial Proton-Translocating ATPases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.